In vitro assays, including cell-cell fusion assays, single-cycle viral infection assays, and replication-competent viral assays, were conducted to evaluate the antiviral potencies of soluble recombinant CCR5-T4L protein. The gene discussed is CCR5; the disease is viral infectious disease.